Researcher.Life Logo

Experimental and Molecular Medicine : Impact Factor & More

eISSN: 2092-6413pISSN: 1226-3613
JournalOpen Access

Key Metrics

CiteScore
15.6
Eigenfactor
0.01 - 0.05
H-Index
104
Impact Factor
10 - 15
SJR
Q1Biochemistry
SNIP
2.26
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Experimental and Molecular Medicine

Experimental and Molecular Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGERNATURE
Language English
Frequency Monthly
Article Processing ChargesEUR 3690 | USD 4290 | GBP 3090
Publication Time5
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorKorean Society of Biochemistry and Molecular Biology
FrequencyMonthly
Publication Start Year1996
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 5
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Experimental and Molecular Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Experimental and Molecular Medicine

Editorial Expression of Concern: Swim training improves leptin receptor deficiency-induced obesity and lipid disorder by activating uncoupling proteins.
  • 21 Nov 2025
  • Experimental & molecular medicine
Methyl-CpG-binding domain 2 mitigates osteoarthritis through Steap3 promoter methylation and chondrocyte ferroptosis regulation.
  • 18 Nov 2025
  • Experimental & molecular medicine
PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways.
  • 18 Nov 2025
  • Experimental & molecular medicine
Failure of lysosomal acidification and endomembrane network in neurodegeneration.
  • 18 Nov 2025
  • Experimental & molecular medicine
Redirecting microglia phenotype via inhibition of NFAT1 ameliorates deficits in mouse model of synucleinopathies.
  • 17 Nov 2025
  • Experimental & molecular medicine
Direct crosstalk between GPCRs and ion channels via G proteins.
  • 16 Nov 2025
  • Experimental & molecular medicine
Editorial Expression of Concern: Swim training improves leptin receptor deficiency-induced obesity and lipid disorder by activating uncoupling proteins.
  • 21 Nov 2025
  • Experimental & molecular medicine
Methyl-CpG-binding domain 2 mitigates osteoarthritis through Steap3 promoter methylation and chondrocyte ferroptosis regulation.
  • 18 Nov 2025
  • Experimental & molecular medicine
PYCR1 drives lung cancer progression through functional interactions with EGFR and TLR signaling pathways.
  • 18 Nov 2025
  • Experimental & molecular medicine
Failure of lysosomal acidification and endomembrane network in neurodegeneration.
  • 18 Nov 2025
  • Experimental & molecular medicine
Redirecting microglia phenotype via inhibition of NFAT1 ameliorates deficits in mouse model of synucleinopathies.
  • 17 Nov 2025
  • Experimental & molecular medicine
Direct crosstalk between GPCRs and ion channels via G proteins.
  • 16 Nov 2025
  • Experimental & molecular medicine

FAQs on Experimental and Molecular Medicine